what is ipamorelin cjc 1295 sermorelin CJC-1295/Ipamorelin (5/5 MG) Ipamorelin/CJC-1295 (no DAC) Blend |

Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG , Sepesi B

Expert Opinion on Therapeutic Targets, 20(10), 12591265

The therapeutic strategy mentioned in the text involves targeting immune organs to counteract immunosenescence by restoring thymic vitality, rejuvenating bone marrow niches, and improving the function of peripheral immune organs, ultimately enhancing the generation and functionality of immune cells

Some use 300 mg daily, others explore doses up to 2,400 mg

It is more common for results to be low, although pituitary tumors (sometimes leading to gigantism or acromegaly) can produce unusual results